← SynDRA
OSI.420
SynDRA canonical compound SYN1970583 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | EGFR |
| Mechanism of action | EGFR inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Desmethyl Erlotinib
- OSI-420
- OSI-420, Free Base (Desmethyl Erlotinib)
- CP-373420
- 2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethanol
- Erlotinib metabolite M14
- 2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethanol
- X78J9Z28DQ
- 2-[[4-[(3-Ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]ethanol
- OSI420
- 2-(4-(3-Ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxyethanol
- Ethanol, 2-((4-((3-ethynylphenyl)amino)-7-(2-methoxyethoxy)-6-quinazolinyl)oxy)-
- 183321-86-0 pound>>183320-51-6
- Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]-
- O-Desmethyl Erlotinib
- osi-420 (free base)
- Desmethyl Erlotinib-[d4]
- Erlotinib, 6-O-Desmethyl-
- UNII-X78J9Z28DQ
- SCHEMBL1507409
- CHEMBL3186743
- BCPP000136
- BCP02398
- EX-A064-1
- HY-13256A
- ZINC22065493
- 2-(4-(3-ethynylphenylamino)-7-(2-methoxyethoxy)quinazolin-6-yloxy)ethanol
- AKOS025289326
- BCP9001036
- NCGC00346578-01
- CS-0003183
- FT-0673312
- FT-0673313
- AB01274806-01
- AB01274806_02
- J-011737
- B2694-263407
Look up OSI.420 in the interactive SynDRA portal →